Tabula Rasa

When I closed down the website I used previously for business purposes, I intended to create a new presence for my business here at hazelbecker.com. I had agreed to work again after a two-year hiatus, thinking I would take on a small publication development project for Bloomberg BNA and then decide how to spend my professional time – the hours each day when I don’t pretend to be retired.

A clean check-up - and an update on advances in melanoma research

Even if 3 ½ years is not a milestone generally marked in cancer survival, we came away from our visit with Dr. Evan Lipson at Johns Hopkins University Hospital yesterday with smiles and relief on two fronts. Not only does Robert continue to show no evidence of disease after his primary melanoma was removed in June 2012, but the report we heard on progress in melanoma research since his diagnosis is exciting and encouraging.

Still N.E.D. - and an update on melanoma research

Our annual trips to Johns Hopkins for Robert’s participation in a follow-up study after his melanoma vaccine trial have become fairly routine. Leave about 7 a.m., check in by 8:30, CT scan and brain MRI, go see the blood-sucker, fit in lunch somewhere along the way, and then see Dr. Lipson early in the afternoon. Today we were home about 2:30. Easy up, easy back, and no news is good news. No evidence of disease.

A future for freelancers?

I was surprised, to say the least, when a longtime friend and fellow journalist recently lamented about the state of the news industry today. He was complaining about staff cuts in newsrooms of all kinds (broadcast, print, digital), layoffs and forced retirements, sparse staffing, and, generally, what he perceives to be a lack of quality standards in the media today.

Pages

Subscribe to www.hazelbecker.com RSS